Stifel Nicolaus analyst Mark Astrachan maintained a Hold rating on Procter & Gamble (PG – Research Report) today and set a price target of ...
Barclays analyst Lauren Lieberman maintained a Hold rating on Procter & Gamble (PG – Research Report) today and set a price target of ...
HNSCC, whereas the combination of durvalumab and cetuximab showed limited success. Abenacianine received fast track designation for lung cancer surgery, the combination of amivantamab and Lazertinib ...
Analysts at Cantor Fitzgerald upped their FY2024 earnings per share (EPS) estimates for shares of Rigel Pharmaceuticals in a ...
Shares of Perrigo Company plc (NYSE:PRGO – Get Free Report) have earned a consensus recommendation of “Hold” from the five analysts that are covering the firm, Marketbeat.com reports. Three analysts ...
Across 5 research centers, investigators evaluated the impact of eculizumab on thymoma-associated myasthenia gravis, a severe ...
Reported reserves are 1.003Bt @ 0.33% Cu & 0.13 g/t Au. EL24001: 261 m of mineralization grading 0.64% copper-equivalent ...
The Department of Justice filed a lawsuit Friday against a Davenport landlord alleging he had sexually harassed female ...
During a Case-Based Roundtable® event, Rahul Banerjee, MD, discussed approaches to dosing and tolerability when using ...
VANCOUVER, BC / ACCESSWIRE / January 15, 2025 / Arras Minerals Corp. (TSXV:ARK)(OTCQB:ARRKF) ("Arras" or "Arras Minerals" or "the Company") is pleased to provide initial results for the first 3 drillh ...
South Dakota Governor Kristi Noem, Donald Trump’s pick for secretary of homeland security, got some heat for rattling off ...
Linsitinib, an oral small molecule under development for the treatment of thyroid eye disease, demonstrated proptosis reduction and safety in the phase 2b/3 LIDS trial, according to a press release ...